Ptc Therapeutics (NASDAQ: PTCT)
Ptc Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ptc Therapeutics Company Info
PTC Therapeutics, Inc. is a biopharmaceutical company. It engages in discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
News & Analysis
Why PTC Therapeutics Soared 15% Higher Today
The company scored a $1 billion upfront payment for expanding a commercial partnership.
FDA Approves First Oral Treatment for Spinal Muscular Atrophy
Roche and PTC Therapeutics will challenge Novartis and Biogen with competitive pricing for Evrysdi.
Why PTC Therapeutics Stock Is Plummeting Today
Investors are showing their displeasure with the biotech's latest clinical update.
Here's Why PTC Therapeutics Fell 24.1% in September
The company more than doubled its cash balance from the end of June with two fundraising transactions.
Here's Why PTC Therapeutics Fell as Much as 12.5% Today
The business is raising cash through two offerings: one of debt and one of common stock.
Why Capital One Financial, PTC Therapeutics, and Quotient Technology Slumped Today
Earnings and some capital moves hurt these stocks.
Here's Why PTC Therapeutics Fell as Much as 11.7% Today
The company announced the pricing of a share offering announced the day before.
Here's Why PTC Therapeutics Dropped 18% in October
The company's development-stage SMA treatment was supposed to knock out the market leader, but now it may be the one at risk of an upset.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.